Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Ardena Invests US$20 million for State-of-the-Art Nanomedicine Facility in Netherlands
Ardena plans to invest US$20 million to open new expanded nanomedicine facility in Oss, Netherlands
Novo Nordisk Invests US$1.8 billion for New Drug Plant in Missouri, USA
Novo Nordisk plans to invest US$18 billion in the construction of a new pharmaceutical manufacturing facility in Missouri, USA
Lonza to Expand with Two Additional Manufacturing Suites in Switzerland
Lonza plans for the expansion of additional bioconjugation capabilities in Switzerland
AmbioPharm Invests US$28mn for the Expansion of Pharmaceutical Manufacturing Site in Shanghai, China
AmbioPharm invests US$28 million for the expansion of pharmaceutical manufacturing site in Shanghai, China
Rentschler Biopharma Plans for the Construction of a New State-of-the-Art Buffer Media Station in Germany
Rentschler Biopharma is set to build a new stateoftheart buffer media station in Laupheim, Germany
Merck Invests US$74.9 million (€70 million) to Expand Manufacturing Capacity in Missouri, USA
Merck is investing $749 million 70 million to enhance its ADC manufacturing capabilities and capacity at its bioconjugation center of excellence in St Louis, Missouri, USA
SK pharmteco Invests US$260 million to Expand Peptide Production in South Korea
SK pharmteco invests US$260 million to expand its small molecule and peptide production capabilities in South Korea A new fivestory, 136,000 squarefoot multipurpose building is being developed to enhance capacity and capabilities
Eurofins Genomics Plans for the Expasnion of Manufacturing Facility in USA
Eurofins Genomics is set to expand its capabilities with the addition of a new GMP oligonucleotide manufacturing facility in the USA The expanded 75,000 square feet facility significantly boosts manufacturing capacity
eXmoor Pharma Plans for the Construction of New Manufacturing Facility in UK
EXmoor Pharma plans for the construction of new GMP cell and gene therapy manufacturing facility in UK The newly constructed facility, designed inhouse as a flexible and scalable manufacturing hub, features integrated process development and analytical labs
Vetter Opens New State-of-the-Art Clinical Production Site in Austria
Vetter palns to open new new stateoftheart clinical production site in AustriaThe new floor will offer additional office space, featuring individual workstations, clusterstyle offices, and meeting rooms In response to the current growth, this investment is made in the Rankweil site
